Clindamycin Hydrochloride

Product NDC: 63739-059
11-digit product format: 637390059
Labeler code: 63739
Product ID: 63739-059_b95a76ad-9b51-692a-e053-2995a90abd1a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Clindamycin Hydrochloride
Dosage form: CAPSULE
Route: ORAL
Labeler: McKesson Corporation dba Sky Packaging
Application: ANDA063083
Marketing category: ANDA
Marketing start: 2007-08-06
Marketing end: 0000-00-00
Substance: CLINDAMYCIN HYDROCHLORIDE
Active strength: 150 mg/1
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	63739-059		I	Inactivated by FDA		2026-10-05
excluded package	package	63739-059	63739-059-10	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 31 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63739-059-10	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63739-059-10	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63739-059-10	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63739-059-10	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63739-059-10	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63739-059-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63739-059-10	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63739-059-10	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63739-059-10	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63739-059-10	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63739-059-10	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63739-059-10	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63739-059-10	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63739-059-10	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A063083-001	CLINDAMYCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL			1991-07-31
A063083-002	CLINDAMYCIN HYDROCHLORIDE	CLINDAMYCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL			2003-03-18

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2022-09-29 23:25 UTC	2022-09	A063083-001	CLINDAMYCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	1991-07-31	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A063083-002	CLINDAMYCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	2003-03-18	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A063083-001	CLINDAMYCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL	AB	1991-07-31	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A063083-002	CLINDAMYCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL	AB	2003-03-18	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A063083-001	CLINDAMYCIN HYDROCHLORIDE	EQ 150MG BASE	CAPSULE / ORAL		1991-07-31	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A063083-002	CLINDAMYCIN HYDROCHLORIDE	EQ 300MG BASE	CAPSULE / ORAL		2003-03-18	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A063083-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A063083-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A063083-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A063083-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A063083-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A063083-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A063083-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A063083-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A063083-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A063083-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A063083-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A063083-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A063083-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A063083-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A063083-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A063083-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A063083-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A063083-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A063083-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A063083-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A063083-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A063083-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A063083-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A063083-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A063083-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A063083-002	AB	1	`ea99ee380514…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A063083-001	AB	1	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A063083-002	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A063083-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A063083-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A063083-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A063083-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A063083-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A063083-002	AB	1	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a46239a7-5963-4008-8cbb-6b9000f497eb	Product name	1	20250721
1426d8f8-b7d5-4053-8554-613df00c0d86	Product name	2	20250616
b382b4e1-6b48-45f6-bffc-e61b00b0ce19	Product name	3	20250317
d8f81258-db12-0761-46cc-8ff6e62e9302	Product name	4	20240422
b7b2fa42-1c77-d724-81f0-87da60a77e79	Product name	3	20240320
b27c7c65-51f2-a62f-e0e6-a26b3a0f8eb0	Product name	3	20230425
e3af9708-3004-7392-4046-5311eaa8bab5	Product name	3	20221128
ffb4bacf-f636-0f7d-0b0d-7a4b151243e3	Product name	9	20220928
b72227d6-0388-43bd-995b-b762d2754cd5	Product name	1	20220706
a92d22e0-3af4-f301-bc88-27ff030b0070	Product name	2	20220316
4a7d44fe-774d-404b-aad0-8a90fe78375a	Product name	4	20211025
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b	Product name	3	20200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992	Product name	4	20190619
5ce6ce33-4f2b-3ce0-757d-e520013280cf	Product name	5	20180719
b92a26f1-6926-4817-be73-e26ab4c2146f	Product name	1	20170602
028d6c95-5012-6976-2075-dee0ae6fefe2	Product name	1	20140508
468b2c08-8adb-8d0f-8257-c6515a061424	Product name	1	20140508
8959fb29-d86f-c521-666a-b4cb22233594	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63739-059-10	2024-01-30	C162847	48780-1	9d75b9d0-3d90-f424-e053-dadaa90a57ce	Clindamycin Hydrochloride Capsules USP
63739-059-10	2021-01-20	C162847	48780-1	9d75b9d0-3d90-f424-e053-dadaa90a57ce	Clindamycin Hydrochloride Capsules USP
63739-059-10	2020-01-31	C162847	48780-1	9d75b9d0-3d90-f424-e053-dadaa90a57ce	Clindamycin Hydrochloride Capsules USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63739-059-10	Clindamycin Hydrochloride	100 in 1 BLISTER PACK	CAPSULE	100		3
63739-059-10	Clindamycin Hydrochloride	10 in 1 BOX, UNIT-DOSE	CAPSULE	10		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63739-059-10	EA - Each	63739-059	2e38f267-c2d8-40b9-8d3b-081bd789c496	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Clindamycin Hydrochloride	ACTIVE INGREDIENT	T20OQ1YN1W	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
Clindamycin	ACTIVE MOIETY	3U02EL437C	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
gelatin	INACTIVE INGREDIENT	2G86QN327L	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
talc	INACTIVE INGREDIENT	7SEV7J4R1U	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CLINDAMYCIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH]	2
Clindamycin Hydrochloride	ACTIVE INGREDIENT	T20OQ1YN1W	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
Clindamycin	ACTIVE MOIETY	3U02EL437C	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
D&C RED NO. 28	INACTIVE INGREDIENT	767IP0Y5NH	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
gelatin	INACTIVE INGREDIENT	2G86QN327L	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
talc	INACTIVE INGREDIENT	7SEV7J4R1U	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON PACKAGING SERVICES BUSINESS UNIT OF MCKESSON CORPORATION]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63739-059	CLINDAMYCIN HYDROCHLORIDE CAPSULE [MCKESSON CORPORATION DBA SKY PACKAGING]	3	Legacy NDC, 2 package rows	20210121_363d5e7d-2734-4a26-8b7c-a75a707dbaae.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
T20OQ1YN1W	CLINDAMYCIN HYDROCHLORIDE	21462-39-5	CLINDAMYCIN HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197518	clindamycin HCl 150 MG Oral Capsule	PSN	363d5e7d-2734-4a26-8b7c-a75a707dbaae	3
197518	clindamycin 150 MG Oral Capsule	SCD	363d5e7d-2734-4a26-8b7c-a75a707dbaae	3
197518	clindamycin (as clindamycin HCl) 150 MG Oral Capsule	SY	363d5e7d-2734-4a26-8b7c-a75a707dbaae	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63739-059-10	63739005910	10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-059-10) > 100 CAPSULE in 1 BLISTER PACK	10 blister pack	2007-08-06	2021-08-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Clindamycin Hydrochloride Capsules USP	Cardinal Health 107, LLC	2022-10-26	HUMAN PRESCRIPTION DRUG LABEL	6
Clindamycin Hydrochloride Capsules USP	McKesson Corporation dba Sky Packaging \| Legacy Pharmaceutical Packaging, LLC	2021-01-20	HUMAN PRESCRIPTION DRUG LABEL	3